Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Raskin

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Journal of Diabetes and Its Complications|March 17, 2004
Immune-mediated disease and secondary failure to oral therapy in type 2 diabetes mellitusLarissa Avilés-Santa, Noel Maclaren, Philip Raskin
Diabetes Care|December 25, 2012
Response to Comment on: Harrison et al. β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 2012;35:1406-1412Lindsay B Harrison, Philip Raskin, Ildiko Lingvay
Diabetes, Obesity & Metabolism|November 6, 2009
Review of clinical trials: update on oral insulin spray formulationPaolo Pozzilli, Philip Raskin, Christopher G Parkin
Diabetes/Metabolism Research and Reviews|July 1, 2009
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetesPhilip Raskin, Titus Gylvin, Wayne Weng, et al.
Diabetes Care|January 5, 2002
The treatment of hypertension in adult patients with diabetesCarlos Arauz-Pacheco, Marian A Parrott, Philip Raskin
Diabetes Care|December 28, 2002
Treatment of hypertension in adults with diabetesCarlos Arauz-Pacheco, Marian A Parrott, Philip Raskin, et al.
Journal of Diabetes and Its Complications|May 10, 2003
Intractable vomiting in diabetic patientsLarissa Avilés-Santa, Timothy K Wolff, Philip Raskin
Diabetes Care|June 29, 2004
Improved glycemic control without weight gain using triple therapy in type 2 diabetesSuzanne M Strowig, M Larissa Avilés-Santa, Philip Raskin
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 18, 2010
A comparison of twice-daily biphasic insulin aspart 70/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label studyRobert J Ligthelm, Titus Gylvin, Tony DeLuzio, et al.
Diabetes Care|September 28, 2002
Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetesSuzanne M Strowig, M Larissa Avilés-Santa, Philip Raskin
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Journal of Diabetes and Its Complications|March 17, 2004
Immune-mediated disease and secondary failure to oral therapy in type 2 diabetes mellitusLarissa Avilés-Santa, Noel Maclaren, Philip Raskin
Diabetes Care|December 25, 2012
Response to Comment on: Harrison et al. β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 2012;35:1406-1412Lindsay B Harrison, Philip Raskin, Ildiko Lingvay
Diabetes, Obesity & Metabolism|November 6, 2009
Review of clinical trials: update on oral insulin spray formulationPaolo Pozzilli, Philip Raskin, Christopher G Parkin
Diabetes/Metabolism Research and Reviews|July 1, 2009
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetesPhilip Raskin, Titus Gylvin, Wayne Weng, et al.
Diabetes Care|January 5, 2002
The treatment of hypertension in adult patients with diabetesCarlos Arauz-Pacheco, Marian A Parrott, Philip Raskin
Diabetes Care|December 28, 2002
Treatment of hypertension in adults with diabetesCarlos Arauz-Pacheco, Marian A Parrott, Philip Raskin, et al.
Journal of Diabetes and Its Complications|May 10, 2003
Intractable vomiting in diabetic patientsLarissa Avilés-Santa, Timothy K Wolff, Philip Raskin
Diabetes Care|June 29, 2004
Improved glycemic control without weight gain using triple therapy in type 2 diabetesSuzanne M Strowig, M Larissa Avilés-Santa, Philip Raskin
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 18, 2010
A comparison of twice-daily biphasic insulin aspart 70/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label studyRobert J Ligthelm, Titus Gylvin, Tony DeLuzio, et al.
Diabetes Care|September 28, 2002
Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetesSuzanne M Strowig, M Larissa Avilés-Santa, Philip Raskin
Pageof 13